|
ZNF22 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.809900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.38380000000738E-06 |
| Normal-vs-Stage2 |
1.254570E-01 |
| Normal-vs-Stage3 |
3.238400E-01 |
| Normal-vs-Stage4 |
2.352200E-01 |
| Stage1-vs-Stage2 |
3.493400E-01 |
| Stage1-vs-Stage3 |
9.057000E-03 |
| Stage1-vs-Stage4 |
2.292500E-02 |
| Stage2-vs-Stage3 |
4.009600E-01 |
| Stage2-vs-Stage4 |
4.700200E-01 |
| Stage3-vs-Stage4 |
8.937800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.173600E-04 |
| Normal-vs-AfricanAmerican |
1.379960E-01 |
| Normal-vs-Asian |
4.086200E-01 |
| Caucasian-vs-AfricanAmerican |
6.339600E-01 |
| Caucasian-vs-Asian |
7.558000E-01 |
| AfricanAmerican-vs-Asian |
9.004200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.339200E-03 |
| Normal-vs-Female |
3.684400E-03 |
| Male-vs-Female |
9.674200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.796570E-01 |
| Normal-vs-Age(41-60Yrs) |
1.637530E-03 |
| Normal-vs-Age(61-80Yrs) |
3.122600E-03 |
| Normal-vs-Age(81-100Yrs) |
4.293400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.490600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.964800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.206000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.733000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.458600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.066000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.203370E-03 |
| Normal-vs-Grade 2 |
1.15670000022661E-07 |
| Normal-vs-Grade 3 |
2.130200E-01 |
| Normal-vs-Grade 4 |
5.275200E-01 |
| Grade 1-vs-Grade 2 |
1.640630E-01 |
| Grade 1-vs-Grade 3 |
2.779900E-04 |
| Grade 1-vs-Grade 4 |
1.74463000000014E-05 |
| Grade 2-vs-Grade 3 |
1.63193999999089E-05 |
| Grade 2-vs-Grade 4 |
2.4068000004096E-07 |
| Grade 3-vs-Grade 4 |
1.051380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.67020011341424E-10 |
| Normal-vs-ccB subtype |
8.461800E-01 |
| ccA subtype-vs-ccB subtype |
4.43000003347294E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.938910E-03 |
| Normal-vs-N1 |
3.119200E-01 |
| N0-vs-N1 |
6.227500E-02 |
|
|
